Kozak & Associates’s MetLife MET Stock Holding History
Bought
Maintained
Sold
Other funds holding MET
Kozak & Associates's MET Position: Q2 2026 in Review
Kozak & Associates reduced its MetLife (MET) stake by 15% in Q2 2026, selling an estimated $161 and leaving 11 shares worth $940. The position accounts for ﹤0.01% of the portfolio, ranked #386.
Kozak & Associates first reported a position in MET in Q3 2021 and has held it in 20 quarters since. The position peaked at $90K in Q4 2022. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.
- Kozak & Associates held 11 shares of MetLife worth $940 as of Q2 2026.
- Kozak & Associates sold 2 MetLife shares in Q2 2026, an estimated $161.
- MetLife made up ﹤0.01% of Kozak & Associates's portfolio in Q2 2026, its #386 holding.
- Kozak & Associates first reported a position in MetLife in Q3 2021 and has held it in 20 quarters since.
- Kozak & Associates's MetLife position peaked at $90K in Q4 2022.
- 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.
Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.